Business India India

JM Financial calls Metropolis Healthcare ‘best-value diagnostic stock’, sees up to 27% upside

Economic Times - Markets
Economic Times - Markets
Aug 28, 2026 · 1:32 PM
0 views
JM Financial calls Metropolis Healthcare ‘best-value diagnostic stock’, sees up to 27% upside
JM Financial has retained its Buy rating on Metropolis Healthcare with a target price of Rs 734, implying 27.2% upside. The brokerage calls it the cheapest among India’s leading listed diagnostic players, citing attractive valuations, network expansion, stronger B2C growth and improving margins as…
Economic Times - Markets
Continue Reading on Economic Times - Markets
This article is aggregated from Economic Times - Markets. Click below to read the full story.
Read Full Story
🔗 Share this story

Related Stories

📰
Install NewsTRP
Get news updates on your phone!